Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Developmental Medicine & Child Neurology

• Publication date

  2013-02-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1111/dmcn.12038PMID 23163951
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Assessment of executive function and attention in children with neurofibromatosis type 1: Relationships between cognitive measures and real-world behavior

  2011cited by this paper
• A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication.

  2010cited by this paper
• Does Cognitive Impairment Explain Behavioral and Social Problems of Children with Neurofibromatosis Type 1?

  2010cited by this paper
• Social and emotional impairment in children and adolescents with ADHD and the impact on quality of life.

  2010cited by this paper
• Examining Autistic Traits in Children with ADHD: Does the Autism Spectrum Extend to ADHD?

  2010cited by this paper
• Prevalence of Autism Spectrum Disorders: Autism and Developmental Disabilities Monitoring Network, United States, 2006. Morbidity and Mortality Weekly Report. Surveillance Summaries. Volume 58, Number SS-10.

  2009cited by this paper
• Social Functioning in Predominantly Inattentive and Combined Subtypes of Children With ADHD

  2009cited by this paper
• Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006.

  2009cited by this paper
• Latent class subtyping of attention-deficit/hyperactivity disorder and comorbid conditions.

  2008cited by this paper
• Evidence for overlapping genetic influences on autistic and ADHD behaviours in a community twin sample.

  2008cited by this paper
• Peer problems in Attention Deficit Hyperactivity Disorder: current status and future directions.

  2008influential reference
• Early Grade Repetition and Inattention Associated With Neurofibromatosis Type 1

  2007cited by this paper
• Peer functioning in children with ADHD.

  2007cited by this paper
• Attention-Deficit/Hyperactivity Disorder and Comorbid Disruptive Behavior Disorders: Evidence of Pleiotropy and New Susceptibility Loci

  2007cited by this paper
• Neurofibromatosis type 1: New insights into neurocognitive issues

  2006cited by this paper
• Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder.

  2006cited by this paper
• in Diagnostic

  2005cited by this paper
• The nature and frequency of cognitive deficits in children with neurofibromatosis type 1

  2005cited by this paper
• Association between the neurofibromatosis‐1 (NF1) locus and autism in the Japanese population

  2004influential reference
• Social skills of children with neurofibromatosis type 1

  2004influential reference
• Attention-deficit/hyperactivity disorder and comorbidities in 18 Paisa Colombian multigenerational families.

  2004cited by this paper
• Psychometric properties of the Vanderbilt ADHD diagnostic parent rating scale in a referred population.

  2003cited by this paper
• Review Article : Cognitive Deficits in Neurofibromatosis 1

  2002cited by this paper
• Reciprocal Social Behavior in Children With and Without Pervasive Developmental Disorders

  2000cited by this paper
• Social and emotional problems in children with neurofibromatosis type 1: evidence and proposed interventions.

  1999influential reference
• Association study of the NF1 gene and autistic disorder.

  1999influential reference
• The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2

  1998influential reference
• Brief Report: The Association of Neurofibromatosis Type 1 and Autism

  1998cited by this paper
• The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2.

  1997cited by this paper
• Controlling the false discovery rate: a practical and powerful approach to multiple testing

  1995cited by this paper

• Metabolic and behavioral effects of neurofibromin result from differential recruitment of MAPK and mTOR signaling.

  2026cites this paper
• Neurofibromatosis review with focus on rehabilitation intervention.

  2025cites this paper
• Unstuck and on target! for children with neurofibromatosis type 1: a feasibility and acceptability study.

  2025cites this paper
• Metabolic and behavioral effects of neurofibromin result from differential recruitment of MAPK and mTOR signaling

  2025cites this paper
• Neurofibromin Deficiency Alters the Patterning and Prioritization of Motor Behaviors in a State-Dependent Manner

  2025cites this paper
• Isolated lateralized overgrowth and the need for tumor screening: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).

  2025cites this paper
• Current states in understanding oligodendroglia-mediated neurological issues in neurofibromatosis type 1 (NF1)

  2025cites this paper
• Neurofibromin deficiency alters the patterning and prioritization of motor behaviors in a state-dependent manner

  2024cites this paper
• RASopathies influences on neuroanatomical variation in children.

  2024cites this paper
• Autism spectrum disorder profiles in RASopathies: A systematic review

  2024influential citation
• Pilot study of the effectiveness of a telehealth group for improving peer relationships for adolescents with neurofibromatosis type 1

  2024cites this paper
• Social Communication in Ras Pathway Disorders: A Comprehensive Review from Genetics to Behavior in Neurofibromatosis Type 1 and Noonan Syndrome.

  2024cites this paper
• Unraveling neuronal and metabolic alterations in neurofibromatosis type 1

  2024cites this paper
• Social challenges, autism spectrum disorder, and attention deficit/hyperactivity disorder in youth with neurofibromatosis type I

  2024influential citation
• Genetic diagnostic yields of 354 Chinese ASD children with rare mutations by a pipeline of genomic tests

  2023cites this paper
• A clinically relevant selective ERK-pathway inhibitor reverses core deficits in a mouse model of autism

  2023cites this paper
• Delineating Visual Habituation Profiles in Preschoolers with Neurofibromatosis Type 1 and Autism Spectrum Disorder: A Cross-Syndrome Study

  2023cites this paper
• Comprehensive neurological evaluation of a cohort of patients with neurofibromatosis type 1 from a single institution.

  2023cites this paper
• Sensory Processing in Children and Adolescents with Neurofibromatosis Type 1

  2023cites this paper
• Social behavior in RASopathies and idiopathic autism

  2022cites this paper
• A Targeted, Low-Throughput Compound Screen in a Drosophila Model of Neurofibromatosis Type 1 Identifies Simvastatin and BMS-204352 as Potential Therapies for Autism Spectrum Disorder (ASD)

  2022cites this paper
• Neurofibromin 1 mediates sleep depth in Drosophila

  2022cites this paper
• The trilateral interactions between mammalian target of rapamycin (mTOR) signaling, the circadian clock, and psychiatric disorders: an emerging model

  2022cites this paper
• Autism Symptoms in Children and Young Adults With Fragile X Syndrome, Angelman Syndrome, Tuberous Sclerosis Complex, and Neurofibromatosis Type 1: A Cross-Syndrome Comparison

  2022cites this paper
• Neurofibromatosis I and II

  2022cites this paper
• Delineating the autistic phenotype in children with neurofibromatosis type 1

  2022cites this paper
• Auts2 regulated autism-like behavior, glucose metabolism and oxidative stress in mice.

  2022cites this paper
• Autism medical comorbidities

  2021cites this paper
• Parent-Reported Social Skills in Children with Neurofibromatosis Type 1: Longitudinal Patterns and Relations with Attention and Cognitive Functioning

  2021cites this paper
• Hyperactive MEK1 Signaling in Cortical GABAergic Neurons Promotes Embryonic Parvalbumin Neuron Loss and Defects in Behavioral Inhibition.

  2021cites this paper
• Clarifying the Pathophysiological Mechanisms of Neuronal Abnormalities of NF1 by Induced-Neuronal (iN) Cells from Human Fibroblasts

  2021cites this paper
• Genetic and Environmental Contributions to Autism Spectrum Disorder Through Mechanistic Target of Rapamycin

  2021cites this paper
• Recommendations for Social Skills End Points for Clinical Trials in Neurofibromatosis Type 1

  2021cites this paper
• The TAND checklist: a useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1

  2020cites this paper
• Neurofibromatosis Type 1 – Cognitive Profile and the Role of Attention Deficit for Cognitive Development

  2020cites this paper
• Neurofibromatosis Type 1 Implicates Ras Pathways in the Genetic Architecture of Neurodevelopmental Disorders

  2020cites this paper
• A Review of Psychological, Social, and Behavioral Functions in the RASopathies

  2020influential citation
• BIROn - Birkbeck Institutional Research Online

  2020cites this paper
• Early differences in auditory processing relate to Autism Spectrum Disorder traits in infants with Neurofibromatosis Type I

  2020cites this paper
• The p21-activated kinases in neural cytoskeletal remodeling and related neurological disorders

  2020cites this paper
• Learning Disabilities and Behaviour in Neurofibromatosis Type 1 Patients

  2020cites this paper
• Neurological Complications in NF1

  2020cites this paper
• Forskolin rapidly enhances neuron‐like morphological change of directly induced‐neuronal cells from neurofibromatosis type 1 patients

  2020cites this paper
• Autism and attention‐deficit/hyperactivity disorders and symptoms in children with neurofibromatosis type 1

  2020cites this paper
• Developmental loss of neurofibromin across distributed neuronal circuits drives excessive grooming in Drosophila

  2020cites this paper
• A Review of Psychological, Social, and Behavioral Functions in the RASopathies

  2020cites this paper
• An executive functioning perspective in neurofibromatosis type 1: from ADHD and autism spectrum disorder to research domains

  2020cites this paper
• Impairments in communication and social interaction in children with neurofibromatosis type 1: Characteristics and role of ADHD and language delay

  2020cites this paper
• Multidisciplinary Approach to Neurofibromatosis Type 1

  2020cites this paper
• Visuo-perceptual correlates of autistic trait expression in children with Fragile X syndrome and Down Syndrome

  2019cites this paper
• A Longitudinal Investigation of Social Functioning in Children with Neurofibromatosis Type 1

  2019influential citation
• Hyperactive MEK1 signaling in cortical GABAergic interneurons causes embryonic parvalbumin-neuron death and deficits in behavioral inhibition

  2019cites this paper
• Guidance for the Clinician in Rendering Pediatric Care Health Supervision for Children With Neuro fi bromatosis Type 1

  2019cites this paper
• Hyperactive MEK1 signaling in cortical GABAergic neurons causes embryonic parvalbumin-neuron death and defects in behavioral inhibition

  2019cites this paper
• Health Supervision for Children With Neurofibromatosis Type 1

  2019cites this paper
• Loss of function in the autism and learning disabilities associated gene Nf1 disrupts corticocortical and corticostriatal functional connectivity in human and mouse

  2019cites this paper
• The association of neurofibromatosis and autism symptomatology is confounded by behavioral problems

  2019cites this paper
• Emotional functioning among children with neurofibromatosis type 1 or Noonan syndrome

  2019cites this paper
• Autism-associated Nf1 deficiency disrupts corticocortical and corticostriatal functional connectivity in human and mouse

  2019cites this paper
• An update on the central nervous system manifestations of neurofibromatosis type 1

  2019cites this paper
• Clinical Management of Children and Adolescents with Neurofibromatosis Type 1 Like Phenotypes and Complex Behavioural Manifestations: A Multidisciplinary and Dimensional Approach

  2019cites this paper
• From bedside to bench and back: Translating ASD models.

  2018cites this paper
• Characterization of early communicative behavior in mouse models of neurofibromatosis type 1

  2018cites this paper
• Emotional and behavioral problems in children and adolescents with neurofibromatosis type 1

  2018influential citation
• Abnormal mTOR Activation in Autism.

  2018cites this paper
• Psychosocial Features of Neurofibromatosis Type 1 in Children and Adolescents

  2018cites this paper
• Autism Spectrum Disorder in an Unselected Cohort of Children with Neurofibromatosis Type 1 (NF1)

  2018cites this paper
• Social skills in children with RASopathies: a comparison of Noonan syndrome and neurofibromatosis type 1

  2018cites this paper
• Social Function and Autism Spectrum Disorder in Children and Adults with Neurofibromatosis Type 1: a Systematic Review and Meta-Analysis

  2018cites this paper
• Neurofibromatosis type 1 as a model system to study molecular mechanisms of autism spectrum disorder symptoms.

  2018cites this paper
• ERK/MAPK signaling and autism spectrum disorders.

  2018cites this paper
• Measurement considerations in pediatric research on autism spectrum disorders.

  2018cites this paper
• Genetic and neurobiological mechanisms underlying aggression subtypes

  2018cites this paper
• RASopathies are associated with a distinct personality profile

  2018cites this paper
• Dysregulated gene expressions of MEX3D, FOS and BCL2 in human induced-neuronal (iN) cells from NF1 patients: a pilot study

  2017cites this paper
• Imaging genetics in neurodevelopmental psychopathology

  2017cites this paper
• Visuoperceptual processing in children with neurofibromatosis type 1: True deficit or artefact?

  2017cites this paper
• Cognitive and Behavioral Disorders in Children with Neurofibromatosis Type 1

  2017cites this paper
• Neurodevelopmental disorders in children with neurofibromatosis type 1

  2017influential citation
• Facial Emotion Recognition, Face Scan Paths, and Face Perception in Children With Neurofibromatosis Type 1

  2017cites this paper
• Drug Treatments for Core Symptoms of Autism Spectrum Disorder: Unmet Needs and Future Directions

  2017cites this paper
• Autism genetics – an overview

  2017cites this paper
• Impaired engagement of the ventral attention system in neurofibromatosis type 1

  2017cites this paper
• Reverse Pathway Genetic Approach Identifies Epistasis in Autism Spectrum Disorders

  2017cites this paper
• Advances in Understanding Autism Spectrum Disorder

  2017cites this paper
• Role of SIRT1/PGC-1α in mitochondrial oxidative stress in autistic spectrum disorder

  2017cites this paper
• Cognitive and Behavioral Disorders in Children with Neurofibromatosis Type 1

  2017cites this paper
• La personnalité des individus atteints de RASopathies

  2017cites this paper
• CRMP2 is necessary for Neurofibromatosis type 1 related pain

  2017cites this paper
• Autism Spectrum Disorder Symptomatology in Children with Neurofibromatosis Type 1

  2017influential citation
• Theory of mind in children with Neurofibromatosis Type 1.

  2016cites this paper
• Disease Burden and Symptom Structure of Autism in Neurofibromatosis Type 1: A Study of the International NF1-ASD Consortium Team (INFACT).

  2016cites this paper
• Brief Report: The Prevalence of Neurofibromatosis Type 1 among Children with Autism Spectrum Disorder Identified by the Autism and Developmental Disabilities Monitoring Network

  2016influential citation
• Brief Report: The Prevalence of Neurofibromatosis Type 1 among Children with Autism Spectrum Disorder Identified by the Autism and Developmental Disabilities Monitoring Network

  2016influential citation
• 3 – Tumour suppressor/DNA-repair disorders

  2016cites this paper
• Brain and behaviour phenotyping of a mouse model of neurofibromatosis type‐1: an MRI/DTI study on social cognition

  2016cites this paper
• mTOR, a Potential Target to Treat Autism Spectrum Disorder

  2016cites this paper
• Social Competence in Children with Neurofibromatosis Type 1: Relationships with Psychopathology and Cognitive Ability

  2016cites this paper
• Executive functioning deficits in children with neurofibromatosis type 1: The influence of intellectual and social functioning

  2016influential citation
• Neurofibromin Loss of Function Drives Excessive Grooming in Drosophila

  2016cites this paper